Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...

Full description

Bibliographic Details

Published in:	Педиатрическая фармакология
Main Authors:	Vera G. Kalugina, Elena A. Vishneva, Leyla S. Namazova-Baranova
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2020-08-01
Subjects:	recurrent urticaria antihistamine omalizumab spontaneous remission
Online Access:	https://www.pedpharma.ru/jour/article/view/1858